Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Multiple metalloenzymes and transcription factors" encompasses two major, heterogeneous classes of metal-dependent proteins: (1) **Metalloenzymes**, which require one or more metal ions (such as Zn, Fe, Cu, Mo, or Mn) for their structural integrity or catalytic activity, and participate in biochemical processes ranging from nucleic acid modification to extracellular matrix degradation; and (2) **metal-ion-dependent transcription factors**, which use metals as cofactors to regulate gene expression, particularly in response to environmental cues like oxidative or metal stress. These protein families are implicated in a wide range of fundamental biological processes (catalysis, gene regulation, redox balance, cell cycle control) and diseases (notably cancer, inflammation, infection, and age-related disorders)[1][2][4][5]. However, this designation is not a single molecular entity and thus cannot serve as a canonical drug target. Note: For pharmacological or biomedical purposes, it is necessary to specify which metalloenzyme (e.g., Matrix metalloproteinase-9), or which transcription factor (e.g., Metal-responsive transcription factor 1), as individual members have distinct roles, ligand specificities, and disease associations[1][2][4][5].
Competitive or allosteric inhibition of metalloenzyme catalytic sites. Zinc or other metal ion chelation. Allosteric modulation of transcription factor–DNA interactions.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple metalloenzymes and transcription factors.